Down-regulation of IGF-1R expression inhibits growth and enhances chemosensitivity of endometrial carcinoma in vitro

Molecular and Cellular Biochemistry

Volumn 353, Issue 1-2, 2011, Pages 225-233

  Shu, Shanrong ^a   Yang, Yuebo ^a   Li, Xiaomao ^a   Li, Tian ^a   Zhang, Yu ^a   Xu, Chengfang ^a   Liang, Changyan ^a   Wang, Xiaoyun ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Chemosensitivity; Endometrial carcinoma; Lentivirus; RNA interference; The type 1 insulin like growth factor receptor

Indexed keywords

CASPASE 9; CISPLATIN; PROTEIN KINASE B; SHORT HAIRPIN RNA; SOMATOMEDIN C RECEPTOR;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE; CELL PROLIFERATION; CHEMOSENSITIVITY; CONTROLLED STUDY; DOWN REGULATION; ENDOMETRIUM CARCINOMA; ENZYME PHOSPHORYLATION; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; LENTIVIRINAE; NUCLEOTIDE SEQUENCE; PROGNOSIS; PROTEIN CLEAVAGE; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CISPLATIN; DOWN-REGULATION; ENDOMETRIAL NEOPLASMS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; INHIBITORY CONCENTRATION 50; LENTIVIRUS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, IGF TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

LENTIVIRUS;

EID: 79959284354     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-0790-9     Document Type: Article

References (25)

1. Kurman RJ, Zaino RJ, Norris HJ (1994) Endometrial carcinoma. In: Kurmann RJ (ed) Blaustein's pathology of the female genital tract, 4th edn. Springer Verlag, New York, pp 447-448
2. Barakat RR, Grisby PW, Sabbatini P (2000) Corpus:epithelial tumors. In: Hoskins WJ, Perez CA, Young RC (eds) Principles and practice of gynecologic oncology, 2nd edn. Lippincott Williams and Wilkins, Philadelphia, pp 919-959
3. Carey MS, Gawlik C, Fung-Kee-Fung M, Chambers A, Oliver T (2006) Systematic review of systemic therapy for advanced or recurrent endometrial cancer. Gynecol Oncol 101:158-167
4. Werner H, Bruchim I (2009) The insulin-like growth factor-I receptor as an oncogene. Arch Physiol Biochem 115:58-71
5. Yavari K, Taghikhani M, Maragheh MG, Mesbah-Namin SA, Babaei MH (2009) Knockdown of IGF-IR by RNAi inhibits SW480 colon cancer cells growth in vitro. Arch Med Res 40:235-240
6. Sachdev D, Hartell JS, Lee AV, Zhang X, YeeD(2004)Adominant negative type I insulin-like growth factor receptor inhibits metastasis of human cancer cells. J Biol Chem 279:5017-5024
7. Wolf S, Lorenz J, Mossner J, Wiedmann M (2010) Treatment of biliary tract cancer with NVP- AEW541: mechanisms of action and resistance. World J Gastroenterol 16:156-166
8. Furukawa J, Wraight CJ, Freier SM, Peralta E, Atley LM, Monia BP, Gleav ME, Cox ME (2010) Antisense oligonucleotide targeting of insulin-like growth factor-1 receptor (IGF-1R) in prostate cancer. Prostate 70:206-218
9. Yavari K, Taghikhani M, Maragheh MG, Mesbah-Namin SA, Babaei MH, Arfaee AJ, Madani H, Mi-rzaei HR (2010) SiRNA-mediated IGF-1R inhibition sensitizes human colon cancer SW480 cells to radiation. Acta Oncol 49:70-75
10. Wang YH, Xiong J, Wang SF, Yu Y, Wang B, Chen YX, Shi HF, Qiu Y (2010) Lentivirus mediated shRNA targeting insulin-like growth factor-1 receptor (IGF-1R) enhances chemosensitivity of osteosarcoma cells in vitro and in vivo. Mol Cell Biochem 341: 225-233
11. Larsson O, Girnita A, Girnita L (2005) Role of insulin-like growth factor 1 receptor signalling in cancer. Br J Cancer 92: 2097-2101 (Pubitemid 40966242)
12. Ryan PD, Goss PE (2008) The emerging role of the insulin-like growth factor pathway as a therapeutic target in cancer. Oncologist 13:16-24 (Pubitemid 351206693)
13. Pavelić J, Radaković B, Pavelić K (2007) The insulin-like growth factor-2 and its receptors (IGF-1R and IGF-2R/mannose6- phosphate) in endometrial adenocarcinoma. Gynecol Oncol 105: 727-735
14. Kurihara S, Hakuno F, Takahashi S (2000) Insulin-like growth factor-I-dependent signal transduction pathways leading to the induction of cell growth and differentiation of human neuroblastoma cell line SH-SY5Y: the roles of MAP kinase pathway and PI3-kinase pathway. Endocr J 47:739-751 (Pubitemid 32118488)
15. Pollak M (2008) Targeting insulin and insulin-like growth factor signalling in oncology. Curr Opin Pharmacol 8:384-392
16. Pollak M (2008) Insulin, insulin-like growth factors and neoplasia. Best Pract Res Clin Endocrinol Metab 22:625-638
17. Pfeffer S (2010) RNA silencing as a natural antiviral defense system in mammals: where are we now? Mol Ther 18:871-872
18. Downward J (2004) RNA interference. BMJ 328:1245-1248
19. Sumimoto H, Kawakami Y (2010) The RNA silencing technology applied by lentiviral vectors in oncology. Method Mol Biol 614:187-199
20. Shu SR, Li XM, Yang YB, Zhang Y, Li T, Liang CY, Wang J (2010) Inhibitory effect of siRNA targeting IGF-1R on endometrial carcinoma. Int Immunopharmacol 11:244-249
21. Dong AQ, Kong MJ, Ma ZY (2007) Down-regulation of IGF-IR using small, interfering, hairpin RNA (siRNA) inhibits growth of human lung cancer cell line A549 in vitro and in nude mice. Cell Biol Int 31:500-507
22. LeRoith D, Helman L (2004) The new kid on the block (ade) of the IGF-1 receptor. Cancer Cell 5:201-202 (Pubitemid 38402109)
23. Niu J, Xu Z, Li XN, Han Z (2007) siRNA-mediated type 1 insulin-like growth factor receptor silencing induces chemosensitization of a human liver cancer cell line with mutant P53. Cell Biol Int 31:156-164 (Pubitemid 46187102)
24. Maloney EK, McLaughlin JL, Dagdigian NE, Garrett LM, Connors KM, Zhou XM, Blattler WA, Chittenden T, Singh R (2003) An anti-insulin-like growth factor I receptor antibody that is a potent inhibitor of cancer cell proliferation. Cancer Res 63: 5073-5083 (Pubitemid 37022647)
25. Hellawell GO, Ferguson DJ, Brewster SF, Macaulay VM (2003) Chemosensitization of human prostate cancer using antisense agents targeting the type 1 insulin-like growth factor receptor. Br J Urol 91:271-277 (Pubitemid 36232849)